StockData
Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc. (MIST) stock

MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.46+0.05 (+11.42%)

Close on Nov 18, 2026Market cap $57.32MP/E –Yield –

Milestone Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Milestone Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was -$61.65M. For fiscal 2025 it was -$49.34M. The highest annual figure on record is -$21.05M in fiscal 2018.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$49.34M–
FY2024Dec 31, 2024-$28.88M–
FY2023Dec 31, 2023-$46.54M–
FY2022Dec 31, 2022-$52.74M–
FY2019Dec 31, 2019-$51.57M–
FY2018Dec 31, 2018-$21.05M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$22.74M–
Q1 FY2026Mar 31, 2026-$16.10M–
Q4 FY2025Dec 31, 2025-$13.06M–
Q3 FY2025Sep 30, 2025-$9.75M–
Q2 FY2025Jun 30, 2025-$12.58M–
Q1 FY2025Mar 31, 2025-$13.96M–
Q4 FY2024Dec 31, 2024-$6.87M–
Q3 FY2024Sep 30, 2024-$7.02M–
Q4 FY2023Dec 31, 2023-$9.83M–
Q3 FY2023Sep 30, 2023-$12.18M–
Q2 FY2023Jun 30, 2023-$10.60M–
Q1 FY2023Mar 31, 2023-$13.94M–
Q4 FY2022Dec 31, 2022-$12.97M–
Q3 FY2022Sep 30, 2022-$11.68M–
Q4 FY2019Dec 31, 2019-$16.70M–
Q3 FY2019Sep 30, 2019-$8.59M–
Q4 FY2018Dec 31, 2018-$7.31M–
Q3 FY2018Sep 30, 2018-$5.59M–
Q2 FY2018Jun 30, 2018-$3.42M–
Q1 FY2018Mar 31, 2018-$4.73M–

More Milestone Pharmaceuticals figures

See a number that looks wrong?